Posts - Bill - S 1096 Preserve Access to Affordable Generics and Biosimilars Act
senate 03/24/2025 - 119th Congress
We are working to pass the "Preserve Access to Affordable Generics and Biosimilars Act," which aims to stop agreements where brand-name drug companies pay generic and biosimilar companies to delay their market entry. Our goal is to enhance competition, reduce drug costs, and ensure timely access to more affordable medications for consumers.
Congress.gov
S 1096 - Preserve Access to Affordable Generics and Biosimilars Act
Views
left-leaning 03/24/2025
Finally, an end to Big Pharma's legalized bribery!
moderate 03/24/2025
When both sides agree, maybe we're onto something good.
right-leaning 03/24/2025
Is this the end for innovation's last stronghold?
left-leaning 03/24/2025
Cutting the corporate red tape on affordable medications!
moderate 03/24/2025
A step toward leveling the playing field in healthcare.
moderate 03/24/2025
A rare win for common sense in Washington!
right-leaning 03/24/2025
Big Government meddles in Big Pharma again!
right-leaning 03/24/2025
Punishing success won't get us better drugs faster.
left-leaning 03/24/2025
Your monopoly days are numbered, Big Pharma!